Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report

被引:0
|
作者
Wang, Jun Yi [1 ]
Hu, Yong Mei [1 ]
Liu, Jian Xiong [1 ]
Luo, Xiao Jia [1 ]
机构
[1] Chengdu Second Peoples Hosp, Qinyun South Rd,10th Ave, Chengdu 610041, Sichuan, Peoples R China
关键词
Acromegalic cardiomyopathy; Heart failure; Cardiac resynchronization therapy; GROWTH-FACTOR-I; ESC GUIDELINES; RISK; PREVALENCE; HORMONE; DISEASE; PROGNOSIS;
D O I
10.1186/s13256-019-2030-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Congestive heart failure is rarely observed in patients with acromegaly. Excessive growth hormone secretion and elevation of insulin-like growth factor 1 contribute to pathological changes in myocyte growth and structure, cardiac contractility, vascular function, and in later stage may progress to cardiac dysfunction. Early recognition of the condition is paramount, though the insidious progression of the disease commonly results in late diagnosis. Current standard regimens of pharmacological therapy, surgical treatment, radiotherapy are designed to normalize serum levels of both insulin-like growth factor 1 and growth hormone. In patients with late-stage heart failure due to acromegalic cardiomyopathy, cardiac resynchronization therapy might be a desirable treatment to help cardiac synchronization, improve symptoms, and eventually reduce hospital admissions together with mortality rates. Case presentation We describe a case of a 49-year-old man with a history of acromegaly who presented to our hospital with a diagnosis of decompensated systolic heart failure. Serial electrocardiograms showed wide (160-200 ms) QRS duration with left bundle branch block. Echocardiography showed severe left ventricular dysfunction that simultaneously achieved a left ventricular ejection fraction of 16%. Surgical indication was rarely assessed by neurosurgeons. Given that the stereotactic radiosurgery together with pharmacotherapy produced infinitesimal effects, cardiac resynchronization therapy was performed. Owing to biventricular synchronization and holding back reverse remodeling, the patient's symptoms were successfully alleviated, and he was discharged from the hospital. Conclusions Congestive heart failure is a rare complication in acromegaly-induced cardiomyopathy (occurs in only 3% of patients). Early diagnosis and treatment with curative drugs more than cardiovascular implantable electronic devices might lead to better surgical outcomes in this group of patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Cardiac-resynchronization therapy in heart failure
    Burri, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 205 - 206
  • [32] Cardiac resynchronization therapy in chronic heart failure
    Perkar, Sanjiv
    Luckie, Matthew
    Khattar, Rajdeep S.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 392 - 398
  • [33] Cardiac resynchronization therapy for heart failure - Reply
    Abraham, WT
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (22): : 1803 - 1804
  • [34] Cardiac resynchronization therapy for congestive heart failure
    Wijetunga, Mevan
    Strickberger, S. Adam
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (01) : 107 - 110
  • [35] Cardiac resynchronization therapy in children with heart failure
    McCanta, Anthony C.
    Perry, James C.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2016, 43 : 17 - 22
  • [36] Cardiac resynchronization therapy in mild heart failure
    Linde, Cecilia
    EUROPACE, 2009, 11 : 72 - 76
  • [37] Cardiac resynchronization therapy in heart failure - In response
    McAlister, FA
    Wiebe, A
    Abraham, W
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 307 - 308
  • [38] Cardiac Resynchronization Therapy for Treatment of Heart Failure
    Ho, Jonathan K.
    Mahajan, Aman
    ANESTHESIA AND ANALGESIA, 2010, 111 (06): : 1353 - 1361
  • [39] Benefits of cardiac resynchronization therapy in heart failure
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (10): : 524 - 524
  • [40] Cardiac resynchronization therapy for advanced heart failure
    Philip B. Adamson
    William T. Abraham
    Current Treatment Options in Cardiovascular Medicine, 2003, 5 (4) : 301 - 309